Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib

Robenacoxib is a veterinary‐approved non‐steroidal anti‐inflammatory drug (NSAID) of the coxib group. It possesses anti‐hyperalgesic, anti‐inflammatory and anti‐pyretic properties. Robenacoxib inhibits the cyclooxygenase (COX)‐2 isoform of COX selectively (in vitro IC(50) ratios COX‐1:COX‐2, 129:1 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lees, Peter, Toutain, Pierre‐Louis, Elliott, Jonathan, Giraudel, Jerome M., Pelligand, Ludovic, King, Jonathan N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541287/
https://www.ncbi.nlm.nih.gov/pubmed/35460083
http://dx.doi.org/10.1111/jvp.13052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541287/
https://www.ncbi.nlm.nih.gov/pubmed/35460083
http://dx.doi.org/10.1111/jvp.13052

Ejemplares similares